2024 · Lui — Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.
Super-Abstract
An 85-year-old woman with progressive fibrosing interstitial lung disease complicated by hospital-acquired pneumonia showed noticeable improvement in lung infiltrations on chest X-ray by day four of hydrogen-assisted therapy, alongside measurable immune changes: resting Treg cells rose, while Fas+ T cell subsets declined. (In Vivo, 2024.)
Commentary
Progressive fibrosing ILD (PF-ILD) associated with IgG4-related disease is rare, poorly understood, and often refractory to standard treatment. The combination with hospital-acquired pneumonia in an 85-year-old on mechanical ventilation represents an extremely high-risk clinical scenario. The observation that chest X-ray infiltrations improved within four days, coinciding with immune phenotype normalisation, is clinically striking — though the concurrent standard care (antibiotics, ventilator management) makes attribution to H₂ alone impossible. The immune markers selected (resting Tregs, Fas+ helper T cells, Fas+ cytotoxic T cells) are mechanistically relevant: Fas-mediated apoptosis and insufficient Treg activity are implicated in lung fibrosis and autoimmune pathology. The case adds to a growing set of reports linking H₂ with Treg upregulation.
Key quotes
- „On the fourth day of hydrogen-assisted therapy, a noticeable improvement in lung infiltrations was observed in chest X-rays as the patient gradually progressed towards weaning off mechanical ventilation.“ — the clinical observation: lung X-ray improvement by day 4 of H₂ therapy
- „A marked increase was observed in resting regulatory T cell levels after treatment, accompanied by a notable decrease in Fas+ helper T cell and cytotoxic T cell subtypes.“ — the immune phenotype shift: Treg up, Fas+ T cells down after H₂
- „This case study highlights the effectiveness of hydrogen-assisted therapy in managing PF-ILD complicated by pneumonia, warranting further research in the future.“ — cautious authors' conclusion: promising but not proven
Our assessment
A case report with unusually specific immune phenotyping that adds biological depth beyond simple clinical observation. The Treg/Fas+ pattern is consistent with H₂'s proposed anti-inflammatory immunomodulation. Limitations: n=1; 85-year-old with multiple concurrent interventions; the 4-day radiological improvement timeline may reflect antibiotic response to pneumonia rather than H₂; no baseline immune data from before H₂ initiation was described relative to pre-disease; no standardised lung function endpoints. Hypothesis-generating only.
Study design
- Type: single case report · n: 1 (85-year-old female) · H₂ delivery: hydrogen-assisted therapy (method not specified in abstract)
- Diagnosis: suspected IgG4-related PF-ILD complicated by hospital-acquired pneumonia, mechanically ventilated
- Observed outcome: chest X-ray improvement by day 4; increased resting Treg cells; decreased Fas+ helper T and Fas+ cytotoxic T cell subsets; progressive weaning from mechanical ventilation
Abstract
BACKGROUND/AIM: Progressive fibrosing interstitial lung disease (PF-ILD) refers to a group of chronic lung conditions commonly associated with immunoglobulin G4-related disorders. It is characterized by progressive scarring (fibrosis) within the pulmonary interstitium, resulting in respiratory failure and early mortality. Some patients do not respond to standard therapeutic interventions. Numerous studies have confirmed the anti-inflammatory and antioxidant properties of molecular hydrogen in various disease models. CASE REPORT: In this report, we present a case study of an 85-year-old female diagnosed with suspected IgG4-related PF-ILD complicated by hospital-acquired pneumonia. On the fourth day of hydrogen-assisted therapy, a noticeable improvement in lung infiltrations was observed in chest X-rays as the patient gradually progressed towards weaning off mechanical ventilation. To assess treatment responses, we compared immune phenotypes before and after hydrogen treatment. A marked increase was observed in resting regulatory T cell levels after treatment, accompanied by a notable decrease in Fas+ helper T cell and cytotoxic T cell subtypes. CONCLUSION: This case study highlights the effectiveness of hydrogen-assisted therapy in managing PF-ILD complicated by pneumonia, warranting further research in the future.
Source & links
Screenshot of the PubMed page
This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.